Tue, Mar 20, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

ConvergEx Group rolls out cogent hedge trak software for hedge funds prepping SEC registration

Monday, February 07, 2011

John Meserve
Opalesque Industry Update: ConvergEx Group announced that its Cogent Consulting division has released the new Hedge Trak broker review software for hedge funds preparing to register with the Securities and Exchange Commission (SEC) on or before July 21, 2011.

After registration with the SEC, best practice calls for hedge funds to document the process and criteria they use to determine payments for research they receive from brokers and independent research providers. A web‐based software, Hedge Trak allows hedge funds to design and run robust broker reviews on a completely self‐administered basis.

“Broker reviews are a critical part of the research procurement and payment process,” said John Meserve, chief executive officer of ConvergEx Research Solutions. “Hedge Trak gives firms the tools needed to manage reviews in a simple, secure, auditable and historically accurate manner without the operational risk associated with Excel or other manual processes.”

“Hedge Trak builds on Cogent's expertise in developing broker review systems for some of the largest hedge funds and long‐only firms in the world,” said Robin Hodgkins, president of ConvergEx’s Cogent Consulting. “Hedge Trak helps hedge funds deliver a complete picture of the value of their research providers to portfolio managers and analysts and can also be used by traders and back‐office personnel to manage their broker list.”

ConvergEx offers a complete suite of neutral, anonymous and transparent commission management services that encompasses every step of the commission management process from broker vote to third‐party payment. www.convergex.com


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. John Paulson, once the industry's largest hedge fund, to return some investors' money[more]

    Komfie Manalo, Opalesque Asia: John Paulson is reported to be retuning some of his investors' money as a number of his hedge funds continue to suffer setbacks, reports

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From FT.com: Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/Streetinsider.com: Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t